Susan Hasty, Publisher
Table of Contents . . . March 1st, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Law Weekly | Other Publications
Alcohol Use - Too many young Czechs are drinking, and drinking too much, health experts say
CTI Molecular Imaging, Inc. - PET equipment maker comments on Medicare and Medcaid coverage for PET
Cardiovascular Systems, Inc. - Orbital Atherectomy System approved for European clinical trial
Cornell University - Regulatory aspect of cardiovascular drug development discussed
CutiCeuticals, Inc. - New psoriasis and eczema treatment awarded U.S. patent
Drug Importation - Two men face federal charges in Lipitor conspiracy
Elan Corporation plc - Japanese office issues patent certificate for NanoCrystal Technology
Frost & Sullivan - Changes in reimbursement structure to aid greater adoption of brachytherapy
Frost & Sullivan - Royalty stacking a top priority in pharmaceutical, biotech sectors, report says
Genaissance Pharmaceuticals, Inc. - Company obtains license to patent linking genetics to cardiac arrhythmias
Generations on Line - Web site designed to help seniors get Medicare drug card information
Healthcare Coverage - Montana Democrats pitch health insurance, prescription plans
ImaRx Therapeutics Inc. - Biopharmaceutical company licenses tissue destruction patent
Legal Issues - Illinois sues pharmaceutical companies for alleged overcharging
Legal Issues - Pharmacist faces drug charges; really 'big deal,' lawman says
Aastrom Biosciences, Inc. - Clinical milestone achieved in phase I/II U.S. bone grafting trial
Access Pharmaceuticals, Inc. - Pharmaceutical firm reports clinical pipeline update
Accuray Incorporated - Georgetown purchases second CyberKnife System
ActivX Biosciences, Inc. - Acquisition of Kyorin Pharmaceutical closed
Agency for Healthcare Research and Quality - Journal focuses on gender differences and medications
Agilent Technologies, Inc. - Microarray, software launched for comparative genomic hybridization studies
Anadys Pharmaceuticals, Inc. - Phase I trial of Isatoribine for hepatitis C initiated
Antisoma plc - Shareholders approve acquisition of Aptamera
Argos Therapeutics - Grant issued for lupus research
Ariad Pharmaceuticals, Inc. - Oncology drug maker reports financial performance, pipeline update
Aspen Education Group - Therapeutic boarding school for overweight teens reports success
Astex Technology - Dr. Peter Ringrose joins board of drug-discovery company
Aurora Discovery - ChemLib microplate product line expanded
Aventis Pasteur - Antibodies to PspA and PsaA in adults with pneumococcal disease characterized
Avian Influenza - Avian flu treatment may be made in Boulder
BioImage A/S - Licensing deal signed for redistribution technology
BioSphere Medical, Inc. - Medical device firm reports 17.4% increase in revenue
Boehringer Ingelheim Canada Ltd. - Tripeptide inhibitors staunch the replication of subgenomic hepatitis C RNA
Brookhaven National Laboratory - PET/MRI scans may help unravel mechanisms of prenatal drug damage
Business Update - Eye institute announces $17M expansion
Cancer Therapy - Pfizer cancer drug shows such promise that trial ended early
Centre National de la Recherche Scientifique - Data advance knowledge in cancer vaccines research
Centre National de la Recherche Scientifique - Fatal TB infection reported despite immune response in absence of MyD88
Chiron Vaccines - Three-year tick-borne encephalitis booster not really necessary
City of Hope National Medical Center, Duarte - Genetically modified cytolytic T cells recognize and kill glioblastoma
Consumers Union - Low-cost generic antidepressants could save consumers $1200 a year or more
Cornell University - Researchers describe findings in oncology studies
Cyberonics, Inc. - FDA deems VNS Therapy System approvable for chronic or recurrent TRD
Cylex, Inc. - Company surpasses $1 million in sales of ImmuKnow Assay
Cyntellect, Inc. - Company announces most recent Cell Xpress biotechnology customer
Dalhousie University - LEEP treatment increases risk of preterm delivery in future pregnancies
Decision Resources, Inc. - Commercial opportunity outlined in pain drug market
Diet & Nutrition - Health officials wage tough fight against tasty Southern-fried staples
Duke University - CyPA and MIF do not have prognostic value in NSCLC patients
Duke University - Studies show expanding HIV screening is cost-effective
Ecopia BioSciences, Inc. - Biotech company reports pipeline update, financial performance
Fatih University, Ankara - Ice application reduces pain of botulinum toxin type-A injections
Finance - Imperial Ginseng Products Ltd. reports 3- and 6-month financial results
Finlay Institute, Havana - Findings describe new data in vaccines adjuvant research
Frost & Sullivan - Raising awareness key to promoting adoption of autoimmune disease diagnostics
Genentech, Inc. - Results presented for Avastin plus the FOLFOX4 chemotherapy regimen
GlaxoSmithKline Biologicals - Diphtheria dTpa or DTPa antibody protection rates similar after 10 years
Global Alliance for TB Drug Development - Dutch development agency renews TB organization's funding
Inst Nacl Enf Vir Humanes Dr Julio I, Buenos Aires - 3 genotypes associated with hantavirus pulmonary syndrome circulating in Yuto
Legal Issues - Potential jurors in nurse case to fill out questionnaires
Ligand Pharmaceuticals Incorporated - Supplemental NDA confirmed for lasofoxifene as a treatment for vaginal atrophy
Neurobiological Technologies, Inc. - Biotechnology firm receives fast-track status for antistroke treatment
New York State Department of Health - Reports add new data to smallpox vaccines research
Norwood Immunology Limited - Immunology company announces bone marrow transplant trial
NovaBone Products LLC - NovaBone stimulates new bone formation on equivalent basis as BMP-2, study shows
PRAECIS PHARMACEUTICALS INCORPORATED - Pharma company reports improved financial results
PTC Therapeutics, Inc. - Orphan drug designation granted to PTC124 for Duchenne muscular dystrophy
Queensland Institute Medical Research, Herston - Spatial-temporal analysis identifies Ross River virus disease outbreaks
Royal Brisbane Hospital, Australia - New mosquito control strategy proves successful against dengue fever
Stanford University - Host ARAP3 production makes cells vulnerable to anthrax toxin
U.S. Army Institute of Infectious Diseases - Crimean-Congo hemorrhagic fever reviewed
U.S. Centers for Disease Control and Prevention - Review finds not enough evidence to say gun laws reduce violence
U.S. Food & Drug Administration - Hepatitis C virus core protein encoded in hepatocellular carcinomas
U.S. Food & Drug Administration - U.S. FDA issues nationwide alert on certain IV Flush preloaded syringes
Univ. of California, Los Angeles - Regulatory approach for PET imaging probes presented
Voyage Pharmaceutical Corp. - Pharmaceutical company closer to developing implant to treat Alzheimer disease
WellSpring Pharmaceutical Corporation - U.S. FDA grants clearance to market drug for urinary tract, bladder disorers
Wyeth Pharmaceuticals - FDA grants Tygacil NDA priority review status
Zila, Inc. - Product containing Zila Tolonium Chloride cleared by FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.